Predictors of two-year mortality in Asian patients with heart failure and preserved ejection fraction

International Journal of Cardiology

Volumn 183, Issue , 2015, Pages 33-38

  Yap, Jonathan ^a   Sim, David ^a   Lim, Choon Pin ^a   Chia, Shaw Yang ^a   Go, Yun Yun ^a   Jaufeerally, Fazlur Rehman ^b   Sim, Ling Ling ^a   Liew, Reginald ^c   Ching, Chi Keong ^a,c  

^a DEPARTMENT OF CARDIOLOGY   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

^c DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

Ethnicity; Heart failure; Mortality; Preserved ejection fraction

Indexed keywords

CREATININE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MINERALOCORTICOID ANTAGONIST; WARFARIN;

AGED; AGING; ARTICLE; ASIAN; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; DRUG USE; ETHNICITY; FEMALE; HEART EJECTION FRACTION; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMOKING; ASIAN CONTINENTAL ANCESTRY GROUP; ELECTROCARDIOGRAPHY; EPIDEMIOLOGY; ETHNOLOGY; HEART FAILURE; HEART STROKE VOLUME; MIDDLE AGED; PHYSIOLOGY; SINGAPORE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SINGAPORE; STROKE VOLUME;

EID: 84926638004     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.01.063     Document Type: Article

References (41)

1. W.J. Paulus, C. Tschöpe, J.E. Sanderson, C. Rusconi, F.A. Flachskampf, F.E. Rademakers, P. Marino, O.A. Smiseth, G. De Keulenaer, A.F. Leite-Moreira, A. Borbély, I. Edes, M.L. Handoko, S. Heymans, N. Pezzali, B. Pieske, K. Dickstein, A.G. Fraser, and D.L. Brutsaert How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology Eur. Heart J. 28 2007 2539 2550
2. T.E. Owan, D.O. Hodge, R.M. Herges, S.J. Jacobsen, V.L. Roger, and M.M. Redfield Trends in prevalence and outcome of heart failure with preserved ejection fraction N. Engl. J. Med. 355 2006 251 259
3. R.S. Vasan, M.G. Larson, E.J. Benjamin, J.C. Evans, C.K. Reiss, and D. Levy Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort J. Am. Coll. Cardiol. 33 1999 1948 1955
4. C.W. Yancy, M. Lopatin, L.W. Stevenson, T. De Marco, G.C. Fonarow, and ADHERE Scientific Advisory Committee and Investigators Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database Am. Coll. Cardiol. 47 2006 76 84
5. G.C. Fonarow, W.G. Stough, W.T. Abraham, N.M. Albert, M. Gheorghiade, B.H. Greenberg, C.M. O'Connor, J.L. Sun, C.W. Yancy, J.B. Young, and OPTIMIZE-HF Investigators and Hospitals Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry J. Am. Coll. Cardiol. 50 2007 768 777
6. R.S. Bhatia, J.V. Tu, D.S. Lee, P.C. Austin, J. Fang, A. Haouzi, Y. Gong, and P.P. Liu Outcome of heart failure with preserved ejection fraction in a population-based study N. Engl. J. Med. 355 2006 260 269
7. M. Tsuchihashi-Makaya, S. Hamaguchi, S. Kinugawa, T. Yokota, D. Goto, H. Yokoshiki, N. Kato, A. Takeshita, H. Tsutsui, and JCARE-CARD Investigators Characteristics and outcomes of hospitalized patients with heart failure and reduced vs preserved ejection fraction. Report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD) Circ. J. 73 2009 1893 1900
8. C. Tribouilloy, D. Rusinaru, H. Mahjoub, V. Soulière, F. Lévy, M. Peltier, M. Slama, and Z. Massy Prognosis of heart failure with preserved ejection fraction: a 5 year prospective population-based study Eur. Heart J. 29 2008 339 347
9. Meta-analysis Global Group in Chronic Heart Failure (MAGGIC) The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis Eur. Heart J. 33 2012 1750 1757
10. D.L. Dries, D.V. Exner, B.J. Gersh, H.A. Cooper, P.E. Carson, and M.J. Domanski Racial differences in the outcome of left ventricular dysfunction N. Engl. J. Med. 340 1999 609 616
11. T.P. Ng, and M. Niti Trends and ethnic differences in hospital admissions and mortality for congestive heart failure in the elderly in Singapore, 1991 to 1998 Heart 89 2003 865 870
12. R. Lee, S.P. Chan, Y.H. Chan, J. Wong, D. Lau, and K. Ng Impact of race on morbidity and mortality in patients with congestive heart failure: a study of the multiracial population in Singapore Int. J. Cardiol. 134 2009 422 425
13. J.J. Atherton, C.S. Hayward, W.A. Wan Ahmad, B. Kwok, J. Jorge, A.F. Hernandez, L. Liang, R.D. Kociol, H. Krum, and ADHERE International-Asia Pacific Scientific Advisory Committee Patient characteristics from a regional multicenter database of acute decompensated heart failure in Asia Pacific (ADHERE International-Asia Pacific) J. Card. Fail. 18 2012 82 88
14. R. West, L. Liang, G.C. Fonarow, R. Kociol, R.M. Mills, C.M. O'Connor, and A.F. Hernandez Characterization of heart failure patients with preserved ejection fraction: a comparison between ADHERE-US registry and ADHERE-International registry Eur. J. Heart Fail. 13 2011 945 952
15. Department of Statistics Singapore Monthly Digest of Statistics Singapore February 2013 Available from: http://www.singstat.gov.sg/publications/publications-and-papers/reference/monthly-digest/mdsfeb13.pdf
16. Ministry of Health Admissions and outpatient attendances Available from: http://www.moh.gov.sg/content/moh-web/home/statistics/Health-Facts-Singapore/Admissions-and-Outpatient-Attendances.html
17. K.T. Ho, K.W. Chin, K.S. Ng, E. Alemao, S. Rajagopalan, and D. Yin The A-SACT (Achievement in Singapore of Cholesterol Targets) study in patients with coronary heart disease Am. J. Cardiovasc. Drugs 6 2006 383 391
18. M.Y. Chan, R.C. Becker, L.L. Sim, V. Tan, C.H. Lee, A.F. Low, S.G. Teo, K.S. Ng, H.C. Tan, and T.C. Yeo Reperfusion strategy and mortality in ST-elevation myocardial infarction among patients with and without impaired renal function Ann. Acad. Med. Singapore 39 2010 179 184
19. S. Ather, W. Chan, B. Bozkurt, D. Aguilar, K. Ramasubbu, A.A. Zachariah, X.H. Wehrens, and A. Deswal Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction J. Am. Coll. Cardiol. 59 2012 998 1005
20. H. Bahrami, R. Kronmal, D.A. Bluemke, J. Olson, S. Shea, K. Liu, G.L. Burke, and J.A. Lima Differences in the incidence of congestive heart failure by ethnicity: the multi-ethnic study of atherosclerosis Arch. Intern. Med. 168 2008 2138 2145
21. A.S. Maisel, J. McCord, R.M. Nowak, J.E. Hollander, A.H. Wu, P. Duc, T. Omland, A.B. Storrow, P. Krishnaswamy, W.T. Abraham, P. Clopton, G. Steg, M.C. Aumont, A. Westheim, C.W. Knudsen, A. Perez, R. Kamin, R. Kazanegra, H.C. Herrmann, and P.A. McCullough Bedside B-type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly multinational study J. Am. Coll. Cardiol. 41 2003 2010 2017
22. Y. Iwanaga, I. Nishi, S. Furuichi, T. Noguchi, K. Sase, Y. Kihara, Y. Goto, and H. Nonogi B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure J. Am. Coll. Cardiol. 47 2006 742 748
23. D.J. van Veldhuisen, G.C. Linssen, T. Jaarsma, W.H. van Gilst, A.W. Hoes, J.G. Tijssen, W.J. Paulus, A.A. Voors, and H.L. Hillege B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction J. Am. Coll. Cardiol. 61 2013 1498 1506
24. B.M. Cheung, and C.R. Kumana Natriuretic peptides - relevance in cardiovascular disease JAMA 280 1998 1983 1984
25. C.M. Carlsen, M. Bay, V. Kirk, J.P. Gøtze, L. Køber, and O.W. Nielsen Prevalence and prognosis of heart failure with preserved ejection fraction and elevated N-terminal pro brain natriuretic peptide: a 10-year analysis from the Copenhagen Hospital Heart Failure Study Eur. J. Heart Fail. 14 2012 240 247
26. W.J. Paulus, and J.J. Van Ballegoij Treatment of heart failure with normal ejection fraction: an inconvenient truth J. Am. Coll. Cardiol. 55 2010 526 537
27. M.M. Chan, and C.S. Lam How do patients with heart failure with preserved ejection fraction die? Eur. J. Heart Fail. 15 2013 604 613
28. D.M. Henkel, M.M. Redfield, S.A. Weston, Y. Gerber, and V.L. Roger Death in heart failure: a community perspective Circ. Heart Fail. 1 2008 91 97
29. S. Hamaguchi, S. Kinugawa, M.A. Sobirin, D. Goto, M. Tsuchihashi-Makaya, S. Yamada, H. Yokoshiki, and H. Tsutsui Mode of death in patients with heart failure and reduced vs. preserved ejection fraction: report from the registry of hospitalized heart failure patients Circ. J. 76 2012 1662 1669
30. S.C. Seow, P. Chai, Y.P. Lee, Y.H. Chan, B.W. Kwok, T.C. Yeo, and B.L. Chia Heart failure mortality in Southeast Asian patients with left ventricular systolic dysfunction J. Card. Fail. 13 2007 476 481
31. B.A. Borlaug, and W.J. Paulus Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment Eur. Heart J. 32 2011 670
32. N.C. Wang, A.P. Maggioni, M.A. Konstam, F. Zannad, H.B. Krasa, J.C. Burnett Jr., L. Grinfeld, K. Swedberg, J.E. Udelson, T. Cook, B. Traver, C. Zimmer, C. Orlandi, M. Gheorghiade, and Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators Clinical implications of QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction JAMA 299 2008 2656 2666
33. S. Iuliano, S.G. Fisher, P.E. Karasik, R.D. Fletcher, S.N. Singh, and Department of Veterans Affairs Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure QRS duration and mortality in patients with congestive heart failure Am. Heart J. 143 2002 1085 1091
34. J.G. Cleland, M. Tendera, J. Adamus, N. Freemantle, L. Polonski, J. Taylor, and PEP-CHF Investigators The perindopril in elderly people with chronic heart failure (PEP-CHF) study Eur. Heart J. 27 2006 2338 2345
35. B.M. Massie, P.E. Carson, J.J. McMurray, M. Komajda, R. McKelvie, M.R. Zile, S. Anderson, M. Donovan, E. Iverson, C. Staiger, A. Ptaszynska, and I-PRESERVE Investigators Irbesartan in patients with heart failure and preserved ejection fraction N. Engl. J. Med. 359 2008 2456 2467
36. S. Yusuf, M.A. Pfeffer, K. Swedberg, C.B. Granger, P. Held, J.J. McMurray, E.L. Michelson, B. Olofsson, J. Ostergren, and CHARM Investigators and Committees Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial Lancet 362 2003 777 781
37. D.J. van Veldhuisen, A. Cohen-Solal, M. Böhm, S.D. Anker, D. Babalis, M. Roughton, A.J. Coats, P.A. Poole-Wilson, M.D. Flather, and SENIORS Investigators Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: data from SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure) J. Am. Coll. Cardiol. 53 2009 2150 2158
38. A. Ahmed, M.W. Rich, J.L. Fleg, M.R. Zile, J.B. Young, D.W. Kitzman, T.E. Love, W.S. Aronow, K.F. Adams Jr., and M. Gheorghiade Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial Circulation 114 2006 397 403
39. F. Edelmann, R. Wachter, A.G. Schmidt, E. Kraigher-Krainer, C. Colantonio, W. Kamke, A. Duvinage, R. Stahrenberg, K. Durstewitz, M. Löffler, H.D. Düngen, C. Tschöpe, C. Herrmann-Lingen, M. Halle, G. Hasenfuss, G. Gelbrich, B. Pieske, and Aldo-DHF Investigators Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial JAMA 309 2013 781 791
40. B. Pitt, M.A. Pfeffer, S.F. Assmann, R. Boineau, I.S. Anand, B. Claggett, N. Clausell, A.S. Desai, R. Diaz, J.L. Fleg, I. Gordeev, B. Harty, J.F. Heitner, C.T. Kenwood, E.F. Lewis, E. O'Meara, J.L. Probstfield, T. Shaburishvili, S.J. Shah, S.D. Solomon, N.K. Sweitzer, S. Yang, S.M. McKinlay, and TOPCAT Investigators Spironolactone for heart failure with preserved ejection fraction N. Engl. J. Med. 370 2014 1383 1392
41. K. Dickstein, A. Cohen-Solal, G. Filippatos, J.J. McMurray, P. Ponikowski, P.A. Poole-Wilson, A. Strömberg, D.J. van Veldhuisen, D. Atar, A.W. Hoes, A. Keren, A. Mebazaa, M. Nieminen, S.G. Priori, K. Swedberg, and ESC Committee for Practice Guidelines (CPG) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology Eur. J. Heart Fail. 10 2008 933 989